You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Norwegian biotech company has announced the appointment of Namir Hassan as chief scientific officer (CSO). “Namir has gathered extensive scientific knowledge in immunology, and, specifically, T-cell receptor based therapies. His experience spans research through to translational developmentAlready a subscriber Login You have read all your free articles, to continue…
The new Chief Medical Officer, Pia Baumann's, role includes overall responsibility for the continued clinical development of the candidate drug fostroxacitabine bralpamide. She will be part of the company's management team and will take up her position on February 20, 2023. "Her experience in Already a subscriber Login You have…
Moberg Pharma appoints Torbjörn Wärnheim, Director Pharmaceutical Innovation and Development, as a member of Moberg’s Management Team. Wärnheim has had this position at Moberg Pharma since 2013. Prior to his position with Moberg, Torbjörn Wärnheim was Vice President R&D at Fresenius KaAlready a subscriber Login You have read all your…
Nordic Nanovector announces the appointment of Gabriele Elbl as Vice President Global Regulatory Affairs. Elbl is a pharmacist with more than 20 years’ experience working in small and large pharmaceutical companies and at the European Medicines Agency (EMA). She brings expertise in all regulatoAlready a subscriber Login You have read…
